![Matthew Notarianni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Notarianni
Investor Relations Contact chez
MIMEDX GROUP, INC.
Profil
Matthew Notarianni is currently Head-Investor Relations at MiMedx Group, Inc. since 2022.
Formerly, Mr. Notarianni was Senior Director-Investor Relations at Cerus Corp.
Mr. Notarianni completed undergraduate studies at Marquette University.
Postes actifs de Matthew Notarianni
| Sociétés | Poste | Début |
|---|---|---|
| MIMEDX GROUP, INC. | Investor Relations Contact | 04/10/2022 |
Anciens postes connus de Matthew Notarianni
| Sociétés | Poste | Fin |
|---|---|---|
| CERUS CORPORATION | Investor Relations Contact | - |
Formation de Matthew Notarianni
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Marquette University
 Marquette University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiMedx Group, Inc.
 MiMedx Group, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets patent protected regenerative biomaterial products and bioimplants | Health Technology |
